Oxomemazine Market Extensive Demand and New Developments in Upcoming years 2022-2030
Oxomemazine Market Advance Technologies forecaste 2022-2030 The latest release from Market.Biz titled, Oxomemazine Market Research Report 2022-2030 (by End-User/Applicant and Regions/Countries), provides an in-depth analysis that includes key market trends, industry drivers, challenges. Oxomemazine, an antihistamine/anticholinergic medication, is used to treat allergies, colds and nausea. It can also be used to treat pruritic. Oxomemazine, a first-generation antihistamine, was approved in the United States for medical use in 1949. It was initially sold under the name Pronestyl. There are generic versions of oxomemazine now. Dry mouth, constipation and dizziness are some of the side effects of oxomemazine. Urinary retention, blurred vision…
- Date: November 14, 2022
- Author: William Tatum
- Category: News